Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.
Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.
复制标题
激活 AhR 通过上调内源性 AB 分解代谢酶脑啡肽酶缓解阿尔茨海默病模型小鼠的认知缺陷
作者:
Qian C;Yang C;Lu M;Bao J;Shen H;Deng B;Li S;Li W;Zhang M;Cao C
Rationale: Neprilysin (NEP) is a major endogenous catabolic enzyme of amyloid β (Aβ). Previous studies have suggested that increasing NEP expression in animal models of Alzheimer's disease had an ameliorative effect. However, the underlying signaling pathway that regulates NEP expression remains unclear. The aryl hydrocarbon receptor (AhR) is a ligand-activated cytoplasmic receptor and transcription factor. Recent studies have shown that AhR plays essential roles in the central nervous system (CNS), but its physiological and pathological roles in regulating NEP are not entirely known. Methods: Western blotting, immunofluorescence, quantitative RT-PCR and enzyme activity assay were used to verify the effects of AhR agonists on NEP in a cell model (N2a) and a mouse model (APP/PS1). Luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay were conducted to investigate the roles of AhR in regulating NEP transcription. Object recognition test and the Morris water maze task were performed to assess the cognitive capacity of the mice. Results: Activating AhR by the endogenous ligand L-Kynurenine (L-KN) or FICZ, or by the exogenous ligand diosmin or indole-3-carbinol (I3C) significantly increases NEP expression and enzyme activity in N2a cells and APP/PS1 mice. We also found that AhR is a direct transcription factor of NEP. Diosmin treatment effectively ameliorated the cognitive disorder and memory deficit of APP/PS1 transgenic mice. By knocking down AhR or using a small molecular inhibitor targeting AhR or NEP, we found that diosmin enhanced Aβ degradation through activated AhR and increased NEP expression. Conclusions: These results indicate a novel pathway for regulating NEP expression in neurons and that AhR may be a potential therapeutic target for the treatment of Alzheimer's disease.
登录
查看更多内容
影响因子:
12.4
作者:
Cearley, CN;Wolfe, JH
通讯作者:
Wolfe, JH
影响因子:
3.5
作者:
Liu, Yinxing;Studzinski, Christa;Beckett, Tina;Murphy, M. Paul;Klein, Ronald L.;Hersh, Louis B.
通讯作者:
Hersh, Louis B.
DOI:
10.1093/brain/awt308
发表时间:
2014-02
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Henderson SJ;Andersson C;Narwal R;Janson J;Goldschmidt TJ;Appelkvist P;Bogstedt A;Steffen AC;Haupts U;Tebbe J;Freskgård PO;Jermutus L;Burrell M;Fowler SB;Webster CI
通讯作者:
Webster CI
影响因子:
14.8
作者:
Leger, Marianne;Quiedeville, Anne;Freret, Thomas
通讯作者:
Freret, Thomas
影响因子:
4.8
作者:
Liang, Kaiwei;Yang, Liuqing;Huang, Jian
通讯作者:
Huang, Jian